Does topical phenylephrine, tropicamide, or proparacaine affect macular blood flow?

Area of Science:

• Ophthalmology
• Microcirculation Research
• Ocular Pharmacology

Background:

• Macular capillary blood flow is crucial for retinal health.
• Assessing the impact of common ophthalmic medications on ocular hemodynamics is important for patient safety and understanding potential side effects.

Purpose of the Study:

• To investigate the acute effects of phenylephrine HCl 10%, tropicamide 1%, and proparacine HCl 0.5% on macular capillary blood flow.
• To quantify changes in leukocyte velocity in retinal macular capillaries following topical administration of these agents.

Main Methods:

• Utilized the blue field simulation technique in six healthy volunteers.
• Measured leukocyte velocity in macular capillaries before and 35 minutes after instillation of study drugs and a 5% NaCl control.
• Participants matched simulated leukocyte velocity to their perceived entoptic velocity.

Main Results:

• No significant differences in leukocyte velocity were observed between the control solution and any of the tested ophthalmic drugs.
• The minimum detectable percentage change in leukocyte velocity with this method was 9% (P < 0.05).
• None of the tested drugs induced changes in macular leukocyte velocity exceeding this detectable threshold.

Conclusions:

• Acute topical administration of phenylephrine HCl, tropicamide, and proparacaine HCl does not significantly affect macular capillary blood flow in healthy individuals.
• These common ophthalmic medications appear safe concerning immediate hemodynamic effects on retinal microcirculation.